We aim to be a key player in the biomedical

innovation licensing market
Know more
Turning biomedical knowledge into economic

and social value and finding its best path to market
Know more
De-risking biomedical innovations increasing

their chance to enter the value chain
Know more

Welcome to Spherium Biomed

Spherium is a company that develops biomedical innovations from academic sources to accelerate their transition to the value chain and to the market.

ENTREPRENEURIAL
MINDSET

Hands-on approach to manage projects with proactivity and flexibility, willing to accept risk and to share success with our partners

KNOWLEDGE OF RESEARCH ENVIROMENT

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator

UNDERSTANDING INDUSTRIAL NEEDS

Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry

FOCUS ON PROJECT MANAGEMENT

Smart approach to project management that helps speed up development stages and decision making

INVESTMENT
CAPABILITY

Availability of own investment up to 500k€ per project allows us to reach the next value milestone

Our mission

Licensing-in biomedical technology

We look for innovation opportunities both in universities &research institutions, and biotech & Pharmaceutical companies

Transforming knowledge into products

After thorough analysis and planning, we conduct the key activities and experiments to achieve the next value milestone

Finding the best way to market

We look for the optimal partner (VC, Pharma…) to keep the project in track towards its next milestone

- Preclinical POC
- Clinical POC
- Partnered
- SP11057
  Aptamers anti-lipoprotein A IV (Apo A IV) - Cancelled
- SP13004
  Prevention and treatment of mucositis induced by cancer chemoradiotherapy
- SP14019
  Topical treatment for psoriasis and atopic dermatitis
- SP12008
  Immunomodulatory biological for the treatment of auto-immune diseases
- SP14037
  Biological for the treatment of Amyotrophic Lateral Sclerosis (ALS). Project canceled

C/ Joan XXIII nº 10. 08950

Esplugues de Llobregat. Barcelona

mail: info@spheriumbiomed.com